| Literature DB >> 3089556 |
I Yamamoto, N Kitamura, J Aoki, C Shigeno, M Hino, K Asonuma, K Torizuka, N Fujii, A Otaka, H Yajima.
Abstract
Synthetic human calcitonin gene-related peptide (CGRP) was examined for the action on the bone in vitro. Human CGRP inhibited bone resorption stimulated by both human parathyroid hormone and basal. The mode of inhibitory action of human CGRP seemed to be similar to that of calcitonin and the relative potency of human CGRP to inhibit bone resorption is one five-hundredth of that of human calcitonin. Thus, a novel pharmacological action of CGRP was demonstrated.Entities:
Mesh:
Substances:
Year: 1986 PMID: 3089556 DOI: 10.1007/bf02555747
Source DB: PubMed Journal: Calcif Tissue Int ISSN: 0171-967X Impact factor: 4.333